Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,148 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00751920 | Comparative Evaluation of MRI and MDCT for the Detection of Metastic Pulmonary Nodules | terminated | Phase 3 | 1 | The Hospital for Sick ChildrenOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT01140347 | A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib(REACH) | completed | Phase 3 | 565 | Eli Lilly and CompanyINDUSTRY |
| 27 |
| Dec 28, 2015 |
| clinicaltrials |
| NCT02058615 | Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast Cancer | completed | Phase 3 | 57 | University of AlbertaOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00006453 | Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy | completed | Phase 3 | — | AGO Study GroupOTHER | 2 | Dec 23, 2015 | clinicaltrials |
| NCT00265824 | Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)(DREAM) | completed | Phase 3 | 700 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 3 | Dec 11, 2015 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
| NCT00389155 | First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy | completed | Phase 2 / Phase 3 | 34 | Bristol-Myers SquibbINDUSTRY | 16 | Dec 7, 2015 | clinicaltrials |
| NCT01223027 | Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 3 | 564 | Novartis PharmaceuticalsINDUSTRY | 27 | Dec 7, 2015 | clinicaltrials |
| NCT00876915 | A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients(PHACS) | terminated | Phase 3 | 218 | University of RochesterOTHER | 2 | Nov 24, 2015 | clinicaltrials |
| NCT00409188 | Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)(START) | completed | Phase 3 | 1,513 | EMD SeronoINDUSTRY | 33 | Nov 20, 2015 | clinicaltrials |
| NCT00006994 | S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat | terminated | Phase 3 | 23 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 18, 2015 | clinicaltrials |
| NCT00003139 | Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer | completed | Phase 3 | 249 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00003162 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer | completed | Phase 3 | 949 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00075686 | S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer | completed | Phase 3 | 766 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT01348126 | Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer(GALAXY) | terminated | Phase 2 / Phase 3 | 385 | Synta Pharmaceuticals Corp.INDUSTRY | 13 | Nov 5, 2015 | clinicaltrials |
| NCT00879333 | Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)(GRANITE-1) | completed | Phase 3 | 656 | Novartis PharmaceuticalsINDUSTRY | 22 | Nov 3, 2015 | clinicaltrials |
| NCT00738881 | Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer(MARVEL) | terminated | Phase 3 | 23 | National Cancer Institute (NCI)NIH | 2 | Oct 29, 2015 | clinicaltrials |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 1,245 | Active Biotech ABINDUSTRY | 37 | Oct 21, 2015 | clinicaltrials |
| NCT00103506 | Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma | completed | Phase 3 | 646 | Janssen Research & Development, LLCINDUSTRY | 17 | Oct 19, 2015 | clinicaltrials |
| NCT00003906 | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women | completed | Phase 3 | 19,747 | NSABP Foundation IncNETWORK | 3 | Oct 6, 2015 | clinicaltrials |
| NCT00085709 | S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML | completed | Phase 3 | 637 | SWOG Cancer Research NetworkNETWORK | 3 | Sep 30, 2015 | clinicaltrials |
| NCT01204801 | Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors(Medifocus301) | unknown | Phase 3 | 238 | Medifocus, Inc.INDUSTRY | 2 | Sep 24, 2015 | clinicaltrials |
| NCT01651182 | Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection | completed | Phase 3 | 24 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 18, 2015 | clinicaltrials |
| NCT00373425 | A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors(RADIANT) | completed | Phase 3 | 1,252 | OSI PharmaceuticalsINDUSTRY | 19 | Sep 17, 2015 | clinicaltrials |
| NCT00057564 | A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma | completed | Phase 3 | 470 | Celgene CorporationINDUSTRY | 16 | Sep 11, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT00256932 | Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | completed | Phase 3 | 518 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 10 | Sep 2, 2015 | clinicaltrials |
| NCT00259922 | Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | completed | Phase 3 | 485 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 12 | Sep 2, 2015 | clinicaltrials |
| NCT00391092 | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 16 | Aug 28, 2015 | clinicaltrials |
| NCT00188305 | A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients | completed | Phase 3 | 252 | University Health Network, TorontoOTHER | 1 | Aug 17, 2015 | clinicaltrials |
| NCT00003636 | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | completed | Phase 3 | 704 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 15 | Aug 5, 2015 | clinicaltrials |
| NCT00044291 | Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | completed | Phase 3 | 865 | Intarcia TherapeuticsINDUSTRY | 4 | Jul 31, 2015 | clinicaltrials |
| NCT01671852 | Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy(Nasonex OSA) | withdrawn | Phase 3 | 0 | Children's & Women's Health Centre of British ColumbiaOTHER | 1 | Jul 30, 2015 | clinicaltrials |
| NCT01638988 | Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin | withdrawn | Phase 3 | 0 | Clinique OvoINDUSTRY | 1 | Jul 28, 2015 | clinicaltrials |
| NCT00510068 | Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors(RADIANT-3) | completed | Phase 3 | 410 | Novartis PharmaceuticalsINDUSTRY | 18 | Jul 1, 2015 | clinicaltrials |
| NCT01103323 | Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy | completed | Phase 3 | 760 | BayerINDUSTRY | 19 | Jun 24, 2015 | clinicaltrials |
| NCT01344967 | Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect(SuBDuE) | completed | Phase 2 / Phase 3 | 21 | University Health Network, TorontoOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01542034 | Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area(REFINE-1) | completed | Phase 3 | 506 | Kythera BiopharmaceuticalsINDUSTRY | 2 | Jun 15, 2015 | clinicaltrials |
| NCT01546142 | Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area | completed | Phase 3 | 516 | Kythera BiopharmaceuticalsINDUSTRY | 2 | Jun 15, 2015 | clinicaltrials |
| NCT01242748 | A Degarelix Trial in Patients With Prostate Cancer | terminated | Phase 3 | 288 | Ferring PharmaceuticalsINDUSTRY | 13 | Jun 3, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT01422928 | Acupuncture for the Immune System in Radiation Cancer Patients | withdrawn | Phase 3 | 0 | British Columbia Cancer AgencyOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01662076 | Homeopathic Treatment of Fatigue in Children Receiving Chemotherapy | completed | Phase 3 | 9 | The Hospital for Sick ChildrenOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00676507 | Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy(STOP) | completed | Phase 3 | 532 | NovaRx CorporationINDUSTRY | 8 | May 8, 2015 | clinicaltrials |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 580 | GlaxoSmithKlineINDUSTRY | 25 | May 6, 2015 | clinicaltrials |
| NCT00891761 | A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | withdrawn | Phase 3 | 0 | GlaxoSmithKlineINDUSTRY | 2 | Apr 17, 2015 | clinicaltrials |
| NCT00501137 | A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine(BCGov-01) | completed | Phase 3 | 830 | Simon DobsonOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT02294149 | Vit D3 and Omega 3 in Chemo Induced Neuropathy | unknown | Phase 3 | 600 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Apr 7, 2015 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials